Designing Continuous Manufacturing Processes for Solid-Dosage Drugs: Development to Commercial Scale

Designing Continuous Manufacturing Processes for Solid-Dosage Drugs: Development to Commercial Scale

04/02/2019, 10:30 AM - 12:00 PM

Javits Conventions Center - Innovation Stage - Booth 1281
Language:
English
Several solid-dosage drugs are now approved for manufacture using continuous processes, and early adopters and equipment manufacturers have been making progress in addressing engineering challenges. Two of the potential advantages of continuous manufacturing compared to batch manufacturing are rapid development and flexibility in scale. This panel discussion will consider what benefits are being realized and what challenges are arising as continuous processes are commercialized. Experts will discuss best practices for and challenges in tech transfer and scale-up/scale-out from development to commercial scale.

Contributors

  • Douglas Hausner

    Speaker

    Associate Director

    Rutgers University/C-SOPS

    Douglas B. Hausner, PhD is currently the Associate Director of C-SOPS located at Rutgers University. C-SOPS focuses on the science based development...

  • Sharon Nowak

    Speaker

    Global Business Development Manager, Food and Pharmaceuticals

    Coperion K-Tron

    Sharon Nowak serves as Global Business Development Manager for the Food and Pharmaceutical Industries for Coperion and Coperion K-Tron. Nowak works...

  • Jose Luis Santos

    Speaker

    Head of Drug Product Continuous Manufacturing

    Hovione

    I am a Chemical Engineer by training (degree and PhD). My academic career included a post-doc research experience, teaching, and leading a research...

  • Jennifer Markarian

    Speaker

    Manufacturing Editor

    UBM Americas

    Jennifer Markarian has been the manufacturing editor at Pharmaceutical Technology and BioPharm International magazines since 2012. She has a chemical...

  • Gregory Connelly

    Speaker

    Director of Continuous Manufacturing

    Vertex Pharmaceuticals

    Greg Connelly is a Director in Formulation Development at Vertex Pharmaceuticals in Boston, MA. He is the Continuous Manufacturing (CM) Lead for Drug...

Type of Session

  1. Type of Session
    Keynote Series

Categories

  1. Track
    Keynote Series

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.